Therapeutic Areas: Cardiology/Vascular Diseases | Hematology

Thrombosis Clinical Trials


A listing of Thrombosis medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Arizona

Glendale : Arrowhead Hospital/Phoenix Heart, PLLC Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Arkansas

Little Rock : Arkansas Children'S Hospital Updated

A clinical research study of Apixaban for the treatment of Thromboembolism

California

Los Angeles :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Los Angeles :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Venous Thrombosis or Pediatrics

Los Angeles : The Elite Laser Vein Center

Patients are needed to participate in a clinical research study to evaluate Varicose Veins, MTHFR, Venous Disease or Thrombosis

Orange : Children'S Hospital Of Orange County Updated

A clinical research study of Apixaban for the treatment of Thromboembolism

Orange : St. Joseph Hospital Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Santa Clara : Abbott Vascular

A clinical trial seeking patients for a research study of XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS)

Stanford : Stanford University Medical Center Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Connecticut

Danbury : Danbury Hospital Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Hartford : Connecticut Children'S Medical Center Updated

A clinical research study of Apixaban for the treatment of Thromboembolism

Norwich : Eastern Connecticut Hematology and Oncology Associates Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Delaware

Newark : Christiana Care

Patients are needed to participate in a clinical research study evaluating EkoSonic Endovascular System for the treatment of Deep Venous Thrombosis or Post-thrombotic Syndrome

Newark : Christiana Care Health Systems Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

District of Columbia

Washington : Medstar Georgetown University Hospital Updated

A clinical research study of Apixaban for the treatment of Thromboembolism

Washington : Childrens Hospital Updated

A clinical research study of Apixaban for the treatment of Thromboembolism

Florida

Orlando : Florida Hospital Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Tampa : Florida Hospital-Tampa Division-Pepin Heart Institute and Dr. Kiran C. Patel Research Institute Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Georgia

Atlanta : Children'S Healthcare Of Atlanta Updated

A clinical research study of Apixaban for the treatment of Thromboembolism

Columbus : Updated

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Illinois

Chicago : Northwestern Medical Faculty Foundation, Div of Hematology/Oncology

A clinical study for patients with Unresectable Hepatocellular Carcinoma With Portal Vein Thrombosis

Chicago :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Venous Thrombosis or Pediatrics

Chicago : University of Illinois at Chicago Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Hinsdale : Adventist Midwest Health Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Winfield : Central DuPage Hospital Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Indiana

Indianapolis :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Venous Thrombosis or Pediatrics

Indianapolis : CorVasc Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Iowa

Iowa City : University of Iowa Carver's College of Medicine Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Kentucky

Florence : St. Elizabeth Healthcare of Northern Kentucky Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Louisville : Kosair Charities Pediatric Clinical Research Unit Updated

A clinical research study of Apixaban for the treatment of Thromboembolism

Maine

Portland : Maine Medical Center Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Rockport : Updated

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Maryland

Baltimore : Johns Hopkins Bayview Medical Center

A clinical research study of Enoxaparin and Fondaparinux for the treatment of Deep Venous Thrombosis or Pulmonary Embolism

Michigan

Ann Arbor : University of Michigan Medical Center Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Ann Arbor : Ann Arbor Veteran's Administration Health System Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Detroit : Updated

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Detroit : Henry Ford Health System Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Minnesota

Rochester : Mayo Clinic Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Missouri

Kansas City : Children'S Mercy Hospital And Clinics Updated

A clinical research study of Apixaban for the treatment of Thromboembolism

St. Louis : Washington University School of Medicine Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Montana

Butte : Updated

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Nebraska

Lincoln : Saint Elizabeth Regional Medical Center Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

New Jersey

New Brunswick : Saint Peter'S University Hospital Updated

A clinical research study of Apixaban for the treatment of Thromboembolism

Teaneck : Holy Name Hospital Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

New York

Buffalo : Kaleida Health System

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

New Hyde Park :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

New York : Icahn School of Medicine at Mount Sinai

A clinical trial seeking patients for a research study for the treatment of Type-2 Diabetes Mellitus or Coronary Artery Disease

New York : Weill Medical College of Cornell University

A clinical trial to evaluate treatments for patients with Thrombus or Myocardial Infarction

New York : Cornell Weill Medical Center Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Staten Island : Staten Island University Hospital Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

North Carolina

Chapel Hill : University of North Carolina at Chapel Hill Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Durham : Duke Children'S Hospital Updated

A clinical research study of Apixaban for the treatment of Thromboembolism

Greensboro : Moses Cone Memorial Hospital

A clinical trial to evaluate treatments for patients with Deep Venous Thrombosis, Pulmonary Embolism or D-dimer

Winston-Salem : Wake Forest University Baptist Medical Center Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

North Dakota

Bismarck : Legacy Pharma Research

Prevention of venous thromboembolism (VTE) in cancer patients at high risk for VTE and who are undergoing chemotherapy

Ohio

Cincinnati : Good Samaritan Hospital Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Cleveland : Cleveland Clinic

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Cleveland : Cleveland Clinic Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Columbus :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Toledo : Promedica Toledo Children'S Hospital Updated

A clinical research study of Apixaban for the treatment of Thromboembolism

Toledo : Jobst Vascular Center Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Oklahoma

Oklahoma City : The University of Oklahoma Health Sciences Center

A clinical trial seeking patients for a research study for the treatment of Deep Venous Thrombosis

Pennsylvania

Allentown : Lehigh Valley Hospital Health Network

A clinical trial to evaluate treatments for patients with Deep Venous Thrombosis, Pulmonary Embolism or D-dimer

Bethlehem : St. Luke's Hospital and Health Network Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Hershey : Penn State Hershey Children'S Hospital Updated

A clinical research study of Apixaban for the treatment of Thromboembolism

Philadelphia : Temple University Hospital Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Pittsburgh : Childrens Hospital Of Pittsburgh Of Upmc Updated

A clinical research study of Apixaban for the treatment of Thromboembolism

Pittsburgh : University of Pittsburgh Medical Center Presbyterian Shadyside Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Pittsburgh : The Western Pennsylvania Hospital Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Pittsburgh : Allegheny General Hospital Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

West Reading : The Reading Hospital and Medical Center Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Rhode Island

Providence : Rhode Island Hospital Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

South Carolina

Charleston : Medical University of South Carolina Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Texas

Dallas : University of Texas Southwestern Medical Center Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Houston :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Virginia

Charlottesville : University of Virginia Health System Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

West Virginia

Morgantown : West Virginia University Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Wisconsin

La Crosse : Gundersen Clinic, Ltd. Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Milwaukee : Childrens Hospital Of Wisconsin Updated

A clinical research study of Apixaban for the treatment of Thromboembolism

Milwaukee : Medical College of Wisconsin/Froedtert Hospital Updated

Patients are needed to participate in a clinical research study of Recombinant tissue plasminogen activator (rt-PA)

Australia

Brisbane :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Parkville :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Venous Thrombosis or Pediatrics

Austria

Graz :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Innsbruck :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Wien :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Venous Thrombosis or Pediatrics

Belgium

Aalst : OLV Ziekenhuis

A clinical trial to evaluate treatments for patients with Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke (WATCHMAN)

Brussels : Erasme Hospital, Brussels

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Edegem : University Hospital Antwerp

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Genk : Ziekenhuis Oost Limburg, Campus St. Jan

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Ghent : Drug Research Unit Ghent

A Phase 1 clinical study for patients with Deep Vein Thrombosis Leg or Stroke (in Patients With Atrial Fibrillation)

Leuven : Updated

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Leuven : Chirurgie UZ Leuven

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Many locations : Updated

A clinical study for patients with Venous Thrombosis

Brazil

Cariacica : Intercath Meridional

Patients are needed to participate in a clinical research study evaluating Inspiron ™ stent eluting sirolimus or Biomatrix™ stent eluting biolimus for the treatment of Coronary Artery Disease

Curitiba : Hospital Cardiologico Costantini

Patients are needed to participate in a clinical research study evaluating Inspiron ™ stent eluting sirolimus or Biomatrix™ stent eluting biolimus for the treatment of Coronary Artery Disease

Goiânia : Encore - Cardiologia e Radiologia Intervencionista

Patients are needed to participate in a clinical research study evaluating Inspiron ™ stent eluting sirolimus or Biomatrix™ stent eluting biolimus for the treatment of Coronary Artery Disease

Porto Alegre : Instituto de Cardiologia do Rio Grande do Sul

Patients are needed to participate in a clinical research study evaluating Inspiron ™ stent eluting sirolimus or Biomatrix™ stent eluting biolimus for the treatment of Coronary Artery Disease

Salvador : Hospital Santa Izabel

Patients are needed to participate in a clinical research study evaluating Inspiron ™ stent eluting sirolimus or Biomatrix™ stent eluting biolimus for the treatment of Coronary Artery Disease

São Paulo : Hospital Santa Marcelina

Patients are needed to participate in a clinical research study evaluating Inspiron ™ stent eluting sirolimus or Biomatrix™ stent eluting biolimus for the treatment of Coronary Artery Disease

São Paulo : Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da USP

Patients are needed to participate in a clinical research study evaluating Inspiron ™ stent eluting sirolimus or Biomatrix™ stent eluting biolimus for the treatment of Coronary Artery Disease

São Paulo : Instituto Dante Pazzanese de Cardiologia

Patients are needed to participate in a clinical research study evaluating Inspiron ™ stent eluting sirolimus or Biomatrix™ stent eluting biolimus for the treatment of Coronary Artery Disease

São Paulo : Santa Casa de Misericórdia de São Paulo

Patients are needed to participate in a clinical research study evaluating Inspiron ™ stent eluting sirolimus or Biomatrix™ stent eluting biolimus for the treatment of Coronary Artery Disease

São Paulo : Instituto de Assistência Médica ao Servidor Publico Estadual

Patients are needed to participate in a clinical research study evaluating Inspiron ™ stent eluting sirolimus or Biomatrix™ stent eluting biolimus for the treatment of Coronary Artery Disease

São Paulo : Hospital Bandeirantes de São Paulo

Patients are needed to participate in a clinical research study evaluating Inspiron ™ stent eluting sirolimus or Biomatrix™ stent eluting biolimus for the treatment of Coronary Artery Disease

Bulgaria

Many Locations :

Patients are needed to participate in a clinical research study of no drug to evaluate Atrial Fibrillation

Sofia : Clinic of Vascular Surgery and Angiology

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Sofia : Tokuda Hospital Sofia

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Sofia :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Varna :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Canada

Edmonton : University Of Alberta - Edmonton Clinic Health Academy Updated

A clinical research study of Apixaban for the treatment of Thromboembolism

Edmonton :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Venous Thrombosis or Pediatrics

Hamilton : St Joseph's Healthcare Hamilton

A clinical research study of Tinzaparin for the treatment of Venous Thrombosis or Pulmonary Embolism

Hamilton :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Venous Thrombosis or Pediatrics

Ottawa :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Toronto : The Hospital For Sick Children Updated

A clinical research study of Apixaban for the treatment of Thromboembolism

Toronto : St. Michael's Hospital

A clinical trial seeking patients for a research study of Atorvastatin and Placebo

Toronto : Princess Margaret Cancer Centre

A clinical trial to evaluate treatments using Upper gastrointestinal endoscopy and Doppler ultrasound for patients with Myeloproliferative Neoplasms (MPN), Polycythemia Vera (PV), Essential Thrombocythemia (ET) or Myelofibrosis (MF)

Toronto :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Venous Thrombosis or Pediatrics

China

Hong Kong : Prince of Wales Hospital

A Phase 0 clinical study for patients with Atrial Fibrillation or Stroke

Czech Republic

Ostrava - Vitkovice : Vascular Centre Vitkovicka Nemocnice

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Prague : Cevni Chirurgie, Nemocnice Na Homolce

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Prague : University Hospital Kralovske Vinobrady

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Prague : IKEM, Kardiologicka klinika

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Praha 1 : Updated

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Usti nad Labem : Chirurgicka klinika IPVZ

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Denmark

Aarhus : Consultant Anne-Mette Hvas

A Phase 4 clinical study for patients with Fetal Growth Retardation

Hellerup : Updated

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Hvidovre : Copenhagen University Hospital Hvidovre

A clinical study for patients with Achilles Tendon Rupture or Deep Vein Thrombosis

France

Aix Les Bains : Cabinet

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Aix-les-Bains : Cabinet

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Alencon : Cabinet

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Amiens : Cabinet

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Amiens : Clinique Victor PAUCHET

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Amiens : CHRU Amiens

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Angers : Chu Angers

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Annecy : Chra Annecy

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Annecy : Cabinet

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Armentieres : CH Armentières

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Armentieres : Centre Hospitalier d'Armentieres

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Arras : Updated

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Bordeaux : Cabinet

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Bourgoin Jallieu : Cabinet

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Bourgoin-Jallieu : Ch Bourgoin-Jallieu

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Brest : Hia Brest

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Brest : Chu Brest

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Caen : CHU

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Carcassonne : Cabinet

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Chalon Sur Saone : Cabinet

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Chalon sur Saone : Ch Chalon Sur Saone

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Chambery : CH de Chambéry

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Clapiers : Cabinet

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Clermont-ferrand : CHU Gabriel Montpied

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Clermont-Ferrand : Chu Clermont-Ferrand

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Creteil :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Dijon : Updated

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Dijon : Cabinet

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Dijon : Hôpital du bocage

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Echirolles : Cabinet

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Genas : Cabinet

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Grenoble : Cabinet

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Grenoble : Chu Grenoble

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Hennebont : Cabinet

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Issy Les Moulineaux : Cabinet

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

La Rochelle : Ch La Rochelle

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Lille : Cabinet

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Lille : Chru Lille

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Limoges Cedex : Updated

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Lomme : Hopital Saint Philibert

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Lyon : CH Pierre-Bénite

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Lyon : Cabinet

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Mâcon : CH Mâcon

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Many locations : Updated

A clinical study for patients with Venous Thrombosis

Many Locations :

Patients are needed to participate in a clinical research study of no drug to evaluate Atrial Fibrillation

Montelimar : Cabinet

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Montigny Les Metz : Cabinet

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Montlucon : Cabinet

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Montpellier : Chu Montpellier

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Montpellier Cedex :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Nantes : Nouvelles Cliniques Nantaises

A clinical trial to evaluate treatments for patients with Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke (WATCHMAN)

Nice : Updated

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Orleans : CHR Orléans

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Paris : HEGP

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Peronne : Cabinet

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Romans sur isère : Cabinet

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Saint Aubin Sur Cie : Cabinet

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Saint Etienne : Updated

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

St Alban : Cabinet

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

St Etienne : Chu St Etienne

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Thonon Les Bains : Cabinet

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Toulouse : Chu Toulouse

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Tournefeuille : Cabinet

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Villeurbanne : Cabinet

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Vizille : Cabinet

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis or Post-thrombotic Syndrome

Georgia

Tblisi : Acad. N. Bokhua Centre of Vascular and Heart Diseases

Patients are needed to participate in a clinical research study of Bemiparin sodium and enoxaparin sodium to evaluate Deep Vein Thrombosis

Germany

Baesweiler : Chriurgische Praxisklinik

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Berlin :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Berlin : Praxis für Chirurgie & Gefäßmedizin

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Berlin : MVZ Ramdohr, Praxis für Cardiovaskulär- u. Ultraschalldiagnostik

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Berlin : Franziskus-Krankenhaus Berlin

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Berlin : Vivantes Klinikum Am Urban

A clinical trial to evaluate treatments for patients with Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke (WATCHMAN)

Berlin : Vivantes Klinikum im Friedrichshain

A clinical trial to evaluate treatments for patients with Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke (WATCHMAN)

Berlin : Charite Universitatsmedizin Berlin - Campus Virchow Klinikum - Medizinische Klinik fur Kardiologie

A clinical trial to evaluate treatments for patients with Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke (WATCHMAN)

Bonn : Universitätsklinikum Bonn, Radiologische Universitätsklinik

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Bonn : Universitatklinikum Medizinische

A clinical trial to evaluate treatments for patients with Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke (WATCHMAN)

Bonn :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Dresden : Universitäts GefäßCentrum Uniklinikum Dresden

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Dresden :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Dresden : Universitätsklinikum Dresden

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Dresden : Krankenhaus Dresden-Friedrichstadt

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Duesseldorf : Dominikus-Krankenhaus

A clinical trial to evaluate treatments for patients with Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke (WATCHMAN)

Eschwege : Gemeinschaftspraxis Eggeling und Winter

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Essen : Elisabeth Krankenhaus

A clinical trial to evaluate treatments for patients with Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke (WATCHMAN)

Frankfurt : Cardioangiologisches Centrum Bethanien

A clinical trial to evaluate treatments for patients with Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke (WATCHMAN)

Frankfurt : Cardio Vasculares Centrum Sankt Katharinen

A clinical trial to evaluate treatments for patients with Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke (WATCHMAN)

Freiburg : Hautarztpraxis

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Görlitz : Oberlausitz-Gefäßpraxis

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Greifswald : Univeritatsmedizin Greifswald

A clinical trial to evaluate treatments for patients with Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke (WATCHMAN)

Hamburg : Asklepios Westklinikum Hamburg

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Hamburg : Aklepios Klinik St Georg

A clinical trial to evaluate treatments for patients with Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke (WATCHMAN)

Heidelberg : Universitätsklinikum Heidelberg

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Hoppegarten : Internistische Praxisgemeinschaft

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Karlsbach : Akademie für Gefäßkrankheiten e.V.

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Köln : Praxis für Allgemeinmedizin un dPhlebologie

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Leipzig : Klinik für Innere Medizin I - Angiologie / Kardiologie

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Leipzig : Universitatklinikum Leipzig

A clinical trial to evaluate treatments for patients with Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke (WATCHMAN)

Lübeck :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Lübeck : Universitätsklinikum Schleswig-Holstein, Campus Lübeck

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Magdeburg : Praxis Dr. Franke

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Mainz : Universitatsmedizin Mainz

A clinical trial to evaluate treatments for patients with Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke (WATCHMAN)

Many Locations :

Patients are needed to participate in a clinical research study of no drug to evaluate Atrial Fibrillation

Mühldorf am Inn : Kardiologie Mühldorf am Inn

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

München : Gemeinschaftspraxis Mietaschk, Bilderling, Kaiser, Tato

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Munich : Stadtisches Klinikum Neuperlach

A clinical trial to evaluate treatments for patients with Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke (WATCHMAN)

Regensburg : Krankenhaus Barmherzige Bruder

A clinical trial to evaluate treatments for patients with Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke (WATCHMAN)

Rostock : Praxis Dr. Kähler

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Rottach-Egern : Praxis für Gefäßmedizin am Tegernsee

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Wiesbaden : Venezentrum Wiesbaden

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

India

Gujarat : Life Care Institute of Medical Sciences and Research

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Karnataka : Gokula Metropolis Clinical Research Centre, M. S. Ramaiah Hospital

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Ireland

Dublin : Beaumont Hospital

A clinical trial to evaluate treatments for patients with Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke (WATCHMAN)

Israel

Jerusalem :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Jerusalem :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Venous Thrombosis or Pediatrics

Ramat Gan : Local Institution Updated

A clinical research study of Apixaban for the treatment of Thromboembolism

Tel Hashomer :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Venous Thrombosis or Pediatrics

Italy

Bari :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Bergamo : Cardiovascular Department Ospedali Riuniti di Bergamo

A clinical trial seeking patients for a research study for the treatment of Coronary Artery Disease

Genova :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Venous Thrombosis or Pediatrics

Milan : Ospedale San Raffaele

A clinical trial to evaluate treatments for patients with Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke (WATCHMAN)

Milano : Fondazione Istituto Nazionale Tumori di Milano

A clinical study for patients with Unresectable Hepatocellular Carcinoma With Portal Vein Thrombosis

Milano :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Milano :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Venous Thrombosis or Pediatrics

Torino :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Torino :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Venous Thrombosis or Pediatrics

Mexico

Guadalajara : Local Institution Updated

A clinical research study of Apixaban for the treatment of Thromboembolism

Mexico : Local Institution Updated

A clinical research study of Apixaban for the treatment of Thromboembolism

Mexico City : Local Institution Updated

A clinical research study of Apixaban for the treatment of Thromboembolism

Monterrey : Local Institution Updated

A clinical research study of Apixaban for the treatment of Thromboembolism

Netherlands

Amsterdam : Academic Medical Center

A clinical research study for the treatment of Deep Venous Thrombosis or Pulmonary Embolism

Amsterdam :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Amsterdam :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Enschede : Medisch Spectrum Twente

A clinical trial to evaluate treatments for patients with Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke (WATCHMAN)

Leeuwarden : Medisch Centrum Leeuwarden

A clinical trial to evaluate treatments for patients with Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke (WATCHMAN)

Nieuwegein : St. Antonius Hospital

A clinical trial to evaluate treatments for patients with Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke (WATCHMAN)

Rotterdam : Erasmus Medisch Centrum Rotterdam

A clinical trial to evaluate treatments for patients with Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke (WATCHMAN)

Peru

Lima : Hospital Nacional Edgardo Rebagliati Martins

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Lima : Instituto Neuro Cardiovascular de las Americas

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Lima : Hospital Nacional Guillermo Almenara Irigoyen-EsSalud

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Lima : Centro de Investigación y Atención Cardiovascular

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Poland

Bytom : Wojewodzki Szpital Specjalistyczny nr 4 w Bytomiu

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Chrzanow : Malopolskie Centrum Sercowo-Naczyniowe PAKS American Heart of Poland Sp. z o.o

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Gdansk : Uniwersyleckie Centrum Kliniczne

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Krakow :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Lodz :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Lublin :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Many Locations :

Patients are needed to participate in a clinical research study of no drug to evaluate Atrial Fibrillation

Poznan : Szpital Kliniczny Przemienienia Panskiego Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Poznan : Zaklad Opieki Zdrowonej Ministerstwa Spraw Wewnetrznych i Administracji w Poznaniu

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Poznan : Clinical Hospital University of Medicine

A clinical trial to evaluate treatments for patients with Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke (WATCHMAN)

Szczecin : Samodzielny Publiczny Szpital Kliniczny Nr 2 PUM w Szczecinie

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Wroclaw :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Portugal

Lisbon : Hospital de Santa Maria

A clinical trial to evaluate treatments for patients with Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke (WATCHMAN)

Romania

Bucuresti : Institutul de Urgenta pentru Boli Cardiovasculare "Prof.Dr.C.C.Iliescu"

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Cluj-Napoca : Institutul Inimii "Nicolae Stancioiu" Cluj-Napoca

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Iasi : Inst.de Boli Cardiovasculare "Prof.I.M.Georgescu" Iasi

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Targu Mures : Institutul de Boli Cardiovasculare si Transplant Mures

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Russian Federation

Many Locations :

Patients are needed to participate in a clinical research study of no drug to evaluate Atrial Fibrillation

Novosibirsk : State Research Institute of Circulation Pathology

A clinical trial to evaluate treatments for patients with Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke (WATCHMAN)

Serbia

Beograd : Institut za kardiovaskularne bolesti Dedinje

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Beograd : Klinicki Centar Srbije

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Nis : Klinicki Centar Nis

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Novi Sad : Klinicki Centar Vojvodine

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Slovakia

Bratislava : Oddelenie diagnostickej a intervencnej radiologie, The National Institute of Cardiovascular Diseases

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Kosice : The Eastern Slovak Institute of Cardiovascular Diseases

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Spain

Alcorcon : Fundacion Hospital Alcorcon

A clinical research study of Plasmin, Plasminogen Activator and Placebo for the treatment of Acute Peripheral Arterial Occlusion

Barcelona : Hospital Clínic Barcelona. IDIBAPS. CIBEREHD. Liver Unit

A clinical study for patients with Unresectable Hepatocellular Carcinoma With Portal Vein Thrombosis

Madrid : Hospital Universitario Puerta de Hierro, Gastroenterology & Hepatology Dept

A clinical study for patients with Unresectable Hepatocellular Carcinoma With Portal Vein Thrombosis

Madrid : Updated

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Salamanca : Hospital Clinico Universitario de Salamanca

A clinical trial to evaluate treatments for patients with Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke (WATCHMAN)

San Sebastián de los Reyes : Updated

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Valencia : Hospital Universitari i Politecnic la Fe

A clinical study for patients with Unresectable Hepatocellular Carcinoma With Portal Vein Thrombosis

Sweden

Göteborg : Updated

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Kristianstad : Updated

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Switzerland

Bern :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Tunisia

Tunis : Hospital Charle Nicolle

A clinical research study of Enoxaparin for the treatment of Deep Vein Thrombosis, Enoxaparin or Anticoagulants

Turkey

Istanbul :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Istanbul :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Many Locations :

Patients are needed to participate in a clinical research study of no drug to evaluate Atrial Fibrillation

Samsun :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Ukraine

Donetsk :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Kiev :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Many Locations :

Patients are needed to participate in a clinical research study of no drug to evaluate Atrial Fibrillation

Uzhhorod :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

United Kingdom

Birmingham : University Hospitals Birmingham NHS Foundation Trust

A clinical study for patients with Unresectable Hepatocellular Carcinoma With Portal Vein Thrombosis

London : Royal Free London NHS Foundation Trust

A clinical study for patients with Unresectable Hepatocellular Carcinoma With Portal Vein Thrombosis

London : Royal Brompton & Harefield NHS Trust

A clinical trial to evaluate treatments for patients with Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke (WATCHMAN)

Poole : BMI The Harbour Hospital

A clinical trial seeking patients for a research study for the treatment of Deep Vein Thrombosis